Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise

Published:2014-07-08 Issue:11 Volume:16 Page:1102-1110
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Kaku K.¹,Kiyosue A.²,Inoue S.³,Ueda N.⁴,Tokudome T.⁵,Yang J.⁶,Langkilde A. M.⁷

Affiliation:

1. Department of Internal Medicine; Kawasaki Medical School; Okayama Japan

2. Tokyo Eki Center-Building Clinic; Tokyo Japan

3. Medical Corporation Heishinkai OCROM Clinic; Osaka Japan

4. AMC Nishi-Umeda Clinic; Osaka Japan

5. Bristol-Myers K.K.; Tokyo Japan

6. AstraZeneca K.K.; Osaka Japan

7. AstraZeneca R&D; Mölndal Sweden

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12325/fullpdf

Reference26 articles.

1. Renal glucose reabsorption inhibitors to treat diabetes;Bailey;Trends Pharmacol Sci,2011

2. Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus;Abdul-Ghani;Endocr Pract,2008

3. Active sugar transport in health and disease;Wright;J Intern Med,2007

4. SGLT2 mediates glucose reabsorption in the early proximal tubule;Vallon;J Am Soc Nephrol,2011

5. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin;Bolinder;J Clin Endocrinol Metab,2012

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study;BMC Endocrine Disorders;2024-08-19

2. Influence of Dapagliflozin Dosing on Low‐Density Lipoprotein Cholesterol in Type 2 Diabetes Mellitus: A Systematic Literature Review and Meta‐Analysis;The Journal of Clinical Pharmacology;2024-08

3. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes;Cochrane Database of Systematic Reviews;2024-05-21

4. Effects of dapagliflozin on body weight in patients with type 2 diabetes mellitus: Evidence‑based practice;Experimental and Therapeutic Medicine;2024-02-28

5. Comparative safety of different recommended doses of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2023-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3